Bipolar Disorder Clinical Trials in Houston

Showing 41-60 of 75 trials

Depression And Bipolar Disorder

NCT00274677

This study is an 8-week evaluation of an investigational drug for treating depression in bipolar patients. Depressed patients will be given either an investigational drug or placebo and receive psychiatric assessments of their depression at weekly visits. Study drug and all study-related visits are provided at no cost to the patient. The patient agrees to meet with study research staff for roughly 11 clinic visits.

Bipolar Disorder

GlaxoSmithKline221 participantsStarted Nov 2003

Burbank, California, United States • Loma Linda, California, United States • San Diego, California, United States +16 more locations

COMPLETEDPhase 4< 1 mile

Bipolar Study in Adults at Least 18 Years of Age

NCT00067938

Bipolar study of tolerability, clinical response and patient satisfaction

Bipolar Disorder

GlaxoSmithKline1,200 participantsStarted Aug 2003

Albertville, Alabama, United States • Anniston, Alabama, United States • Birmingham, Alabama, United States +305 more locations

Depression And Bipolar Disorder

Bipolar Study in Adults at Least 18 Years of Age

Bipolar Disorder Trials in Other Cities

Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression

Efficacy and Safety of Asenapine in the Prevention of Recurrence of Mood Episodes in Participants With Bipolar 1 Disorder (P06384)

CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness

A Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depressive Episode

Aripiprazole in Patients With Acute Mania

Quetiapine Fumarate (SEROQUEL) Compared to Placebo in the Treatment of Children & Adolescents With Bipolar I Mania

Controlled Study of the Use of Quetiapine Fumarate in the Treatment of Patients With Bipolar Depression

Study of Outcome and Safety of Lithium, Divalproex and Risperidone for Mania in Children and Adolescents

Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex

This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296

Pediatric Bipolar Depression

A Study to Evaluate the Efficacy and Safety of Flexible Doses of Extended-release (ER) Paliperidone Compared With Flexible Doses of Quetiapine and Placebo in Patients With Bipolar I Disorder

Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Monotherapy)

Study Evaluating Bifeprunox in Bipolar Depression

Seroquel in Bipolar Depression Versus SSRI

Safety and Efficacy Study of Ramelteon (TAK-375) Tablets for Sublingual Administration (SL) in Adults With Bipolar 1 Disorder

Study of Aripiprazole in Patients With Acute Bipolar Mania

Study of Aripiprazole in the Treatment of Patients With Acute Symptoms of Bipolar Disorder

Other Conditions in Houston